IDENIX PHARMACEUTICALS INC — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b28457e9-8904-4825-ad9c-b39587b821ef/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2013 | $469.0k | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-073142 |
| FY 2012 | $69.7M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-074136 |
| FY 2011 | $7.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-097966 |
| FY 2010 | $10.2M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-097966 |
| FY 2009 | $12.6M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-097966 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
IDENIX PHARMACEUTICALS INC — all facts · Net Income · Operating Income